A Novel HDAC1/2 Inhibitor Improves Measures of Tissue Function in Aged Mice
Researchers have discovered a drug candidate that inhibits histone deacetylases HDAC1 and HDAC2, resulting in positive changes in a number of measures of tissue function in aged mice. This compound, known as Cmpd60, emulates diverse longevity interventions and has shown promising results in improving age-related phenotypes in multiple organs. The findings hold promise for therapeutic translation to promote healthy aging in humans. For more information, visit the following link: Link.
